home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Surgery Partners, Inc. - Common Stock (NQ:SGRY)

15.26 -0.19 (-1.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Preview: Surgery Partners's Earnings ↗

February 23, 2024

Via Benzinga

Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock ↗

January 31, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (NASDAQ: SGRY). "That industry has been up and down and up and down," he added.

Via Benzinga

Surgery Partners feeling no pinch from macroeconomic weakness

January 16, 2024

Surgery Partners Inc. (NASDAQ: SGRY) is a leading healthcare services provider that owns and operates over 180 outpatient surgical centers in 31 states.

Via MarketBeat

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 14, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday ↗

November 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

The Latest Analyst Ratings for Surgery Partners ↗

October 12, 2023

Via Benzinga

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

September 20, 2023

From Teladoc Health, Inc.

Via GlobeNewswire

Expert Ratings for Surgery Partners ↗

September 14, 2023

Via Benzinga

A Preview Of Surgery Partners's Earnings ↗

July 31, 2023

Via Benzinga

Analyst Expectations for Surgery Partners's Future ↗

July 31, 2023

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Where Surgery Partners Stands With Analysts ↗

June 02, 2023

Via Benzinga

Surgery Partners Stock Getting Closer To Key Technical Benchmark ↗

August 01, 2023

The Relative Strength Rating for Surgery Partners stock jumped into a higher percentile Tuesday, as it got a lift from 69 to 74.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

June 16, 2023

Via Benzinga

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

June 16, 2023

Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.

Via MarketBeat

Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review ↗

June 16, 2023

Stocks kept powering higher despite, but the Nasdaq is looking extended.

Via Investor's Business Daily

Expert Ratings for Surgery Partners ↗

May 02, 2023

Via Benzinga

Earnings Preview For Surgery Partners ↗

April 28, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Analyst Expectations for Surgery Partners's Future ↗

January 18, 2023

Via Benzinga

NextDecade, GigaCloud Technology And Other Big Stocks Moving Higher On Wednesday ↗

June 14, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout ↗

June 14, 2023

UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023 ↗

June 02, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Tenet Healthcare Stock Shows Rising Price Performance With Jump To 84 RS Rating ↗

April 13, 2023

On Thursday, Tenet Healthcare stock received an upgrade to its Relative Strength (RS) Rating, from 80 to 84.

Via Investor's Business Daily

Tenet Healthcare Stock Trying To Close In On Key Technical Benchmark ↗

April 05, 2023

A Relative Strength Rating upgrade for Tenet Healthcare shows improving technical performance. Will it continue?

Via Investor's Business Daily

Surgery Partners Stock Gets Technical Rating Upgrade ↗

February 28, 2023

In a welcome move, Surgery Partners stock saw its Relative Strength Rating improve from 65 to 77 on Tuesday.

Via Investor's Business Daily

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023 ↗

April 21, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com